These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7173306)

  • 21. Chromatographic separation of thioridazine sulphoxide and N-oxide diastereoisomers: identification as metabolites in the rat.
    Watkins GM; Whelpton R; Buckley DG; Curry SH
    J Pharm Pharmacol; 1986 Jul; 38(7):506-9. PubMed ID: 2875150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partitioning of thioridazine and mesoridazine in human blood fractions.
    Dinovo EC; Pollak H; Gottschalk LA
    Methods Find Exp Clin Pharmacol; 1984 Mar; 6(3):143-6. PubMed ID: 6748818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans.
    Hartigan-Go K; Bateman DN; Nyberg G; Mårtensson E; Thomas SH
    Clin Pharmacol Ther; 1996 Nov; 60(5):543-53. PubMed ID: 8941027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous assay of thioridazine and its major metabolites in plasma at single dosage levels with a novel report of two ring sulfoxides of thioridazine.
    Wells CE; Juenge EC; Furman WB
    J Pharm Sci; 1983 Jun; 72(6):622-5. PubMed ID: 6875822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorption and excretion of thioridazine and mesoridazine in man.
    Charalampous KD; Johnson PC; Estevez V
    Dis Nerv Syst; 1974 Nov; 35(11):494-6. PubMed ID: 17896456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid concentrations of thioridazine and its main metabolites in psychiatric patients.
    Nyberg G; Axelsson R; Mårtensson E
    Eur J Clin Pharmacol; 1981 Jan; 19(2):139-48. PubMed ID: 7202474
    [No Abstract]   [Full Text] [Related]  

  • 27. S-oxidation of thioridazine to psychoactive metabolites: an oral dose-proportionality study in healthy volunteers.
    Chakraborty BS; Hawes EM; McKay G; Hubbard JW; Korchinski ED; Midha KK; Choc MG; Robinson WT
    Drug Metabol Drug Interact; 1988; 6(3-4):425-37. PubMed ID: 3271648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrocardiographic changes and serum concentrations in thioridazine-treated patients.
    Axelsson R; Aspenstrom G
    J Clin Psychiatry; 1982 Aug; 43(8):332-5. PubMed ID: 7096274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between serum sialic acid and sialylated glycoproteins in alcoholics.
    Chrostek L; Cylwik B; Krawiec A; Korcz W; Szmitkowski M
    Alcohol Alcohol; 2007; 42(6):588-92. PubMed ID: 17573378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A fixed dose study of the plasma concentration and clinical effects of thioridazine and its major metabolites.
    Cohen BM; Lipinski JF; Waternaux C
    Psychopharmacology (Berl); 1989; 97(4):481-8. PubMed ID: 2498945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disparate serum thioridazine concentrations: liquid chromatography versus radioreceptor assay.
    Linnoila M; Rosenblatt JE; Jeste D; Skinner T; Potter WZ; Wyatt RJ
    Acta Pharmacol Toxicol (Copenh); 1982 Jan; 50(1):25-9. PubMed ID: 7064715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of thioridazine in psychiatric patients and healthy volunteers.
    Mårtensson E; Roos BE
    Eur J Clin Pharmacol; 1973 Oct; 6(3):181-6. PubMed ID: 4762056
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics of single doses of sulphinpyrazone and its major metabolites in plasma and urine.
    Bradbrook ID; John VA; Morrison PJ; Rogers HJ; Spector RG
    Br J Clin Pharmacol; 1982 Feb; 13(2):177-85. PubMed ID: 7059415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of chlorpromazine and thioridazine metabolites in human erythrocytes.
    Zingales IA
    J Chromatogr; 1969 Nov; 44(3):547-62. PubMed ID: 4311408
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum neuroleptic concentrations and tardive dyskinesia.
    Jeste DV; Linnoila M; Wagner RL; Wyatt RJ
    Psychopharmacology (Berl); 1982; 76(4):377-80. PubMed ID: 6126895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum concentration and elimination from serum of thioridazine in psychiatric patients.
    Axelsson R; Mårtensson E
    Curr Ther Res Clin Exp; 1976 Feb; 19(2):242-65. PubMed ID: 813963
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of a synthetic diet on the pharmacokinetics of ethyl methyl sulphide and its sulphoxide and sulphone metabolites in rats.
    Nnane LP; Damani LA; Hutt AJ
    Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):17-24. PubMed ID: 11554429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Degradation and configurational changes of thioridazine 2-sulfoxide.
    de Gaitani CM; Martinez AS; Bonato PS
    J Pharm Biomed Anal; 2004 Nov; 36(3):601-7. PubMed ID: 15522536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of zimeldine in male alcoholics.
    Gottfries CG; Grind M; Lundström J; Alling C
    Acta Pharmacol Toxicol (Copenh); 1986 Aug; 59(2):94-102. PubMed ID: 2946168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artifacts in the analysis of thioridazine and other neuroleptics.
    Eap CB; Koeb L; Baumann P
    J Pharm Biomed Anal; 1993 Jun; 11(6):451-7. PubMed ID: 8104489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.